I help boards, owners, CFOs and commercial directors of companies with broad portfolios, multiple sales channels and complex discount systems — mainly in FMCG, retail and distribution — find out how much of the list price really reaches the invoice, and make pricing and financial decisions on reconciled numbers.
For more than 20 years I was accountable for such decisions from inside the business: at Unilever, Makro, Flora Food Group (formerly Upfield) and Super-Pharm — as controller, regional CFO and board member.
That is where it shows fastest whether a company earns on what it sells. Controlling, board support and market analysis complement it when the decision requires. Every project ends with a model, a recommendation and an implementation plan — not a diagnosis alone. Work usually opens with a price and margin realisation diagnostic: a free introductory call, then a paid diagnostic scoped after a look at a data sample.
How much of the list price reaches the invoice — and how to make it more.
Finance that keeps pace with the business and shows one consistent picture every month.
An independent CFO voice on decisions that cannot be undone.
What the market is worth, how competitors price and where the room to grow is.
Warsaw · projects across Europe · Polish and EnglishInternational CFO and board member with 20+ years across FMCG, retail and wholesale in Central and Eastern Europe. Six years in a KKR portfolio company, with full P&L and cash-flow ownership of a EUR 400m+ multi-country cluster and a track record in revenue growth management (RGM), refinancing and value creation.
Most recently CFO and board member of Super-Pharm Poland (PLN 1.4bn revenue, 20+ legal entities), leading cost and liquidity stabilisation and a complex structural separation. Experienced on both sides of a carve-out: built the finance function of a business spun out of Unilever, then separated a business as seller.
At Way2Great Advisory he runs projects personally: does the analysis, builds the model and presents the conclusions to the board himself. Open to supervisory board and audit committee roles.
Articles on pricing, margin and finance from a board perspective, plus one download. The same standard as in projects: named sources, clear method, no false precision.
Questions worth asking the team before the board approves another increase: on discounts, sales mix, competitors and who is accountable for the invoice price. PDF, free.
A free 45-minute introductory call. Tell me what decision you are facing and what data you have — I will say whether a diagnostic makes sense and where to start.